Sharing the Sights of BioMedical and Pharmaceutical Domains on Demo-DVD

CAST PHARMACAST PHARMA, a premier European 3D pharmaceutical and biomedical animation production company, is pleased to announce the availability of an advanced Demo-DVD to make its audiovisual material more widely available to the existing and further customers from the biomedical and pharmaceutical domains.

"This initiative reflects the CAST PHARMA's commitment to better explain and share its realizations and achievements on advanced and scientifically accurate 3D animation techniques - such as "mode of action" at the molecular, cellular, tissue or organ levels," said Mr. Stefan Wolf, CAST PHARMA owner.

Pharma marketing, brand and product professionals can explore the latest CAST PHARMA's 3D videos, on a wide-range of topics: Immunology, Respiratory Tract, Dermatology, Endocrinology, Gastroenterology, Cardiovascular, Ophthalmology, Neurology/Pain, etc. All videos are available on a promotional DVD with an easy and intuitive interface.

"It is very important for us to use all the means at our disposal when it comes to enhancing our communication capabilities with our current and further customers," explained Mr. Stefan Wolf.

With the extended capabilities of its Demo-DVD, CAST PHARMA will focus on promoting its advanced 3 D visualization techniques and services. By announcing the DVD, CAST PHARMA has confirmed its leading position as an advanced and highly professional 3D animations production company.

"We encourage pharmaceutical professionals to request our Demo-DVD, available free of charge, from CAST PHARMA web page. DVD content would serve as example of how our customers are promoting their messages and differentiate themselves from their competitors with scientifically accurate and visually compelling 3D animations," concluded Mr. Wolf.

For further information, please visit:

About CAST PHARMA
CAST PHARMA is a premier European 3D pharmaceutical and biomedical animation production company. For more information, please visit www.cast-pharma.com.

Most Popular Now

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...